It means that young and middle-aged adults with CYP2C19 loss-of-function variants and traditional risk factors (smoking, hypertension, diabetes mellitus, and dyslipidemia) need to be aware of the risk of developing CI. This evidence concerns the gene CYP2C19 and hypertensive disorder.